Pj. Pauwels et C. Palmier, FUNCTIONAL-EFFECTS OF THE 5-HT1D RECEPTOR ANTAGONIST GR-127,935 AT HUMAN 5-HT1D-ALPHA, 5-HT1D-BETA, 5-HT1A AND OPOSSUM 5-HT1B RECEPTORS, European journal of pharmacology. Molecular pharmacology section, 290(2), 1995, pp. 95-103
The functional activity and selectivity of the novel 5-HT1D receptor a
ntagonist GR 127,935 (2'-methyl-4'-(5-methyl-1,2,4 oxadiazol-3-yl)-bip
henyl-4-carboxylic acid methoxy-3-(4-methyl-piperazin-1-yl)-phenyl]-am
ide) was investigated at cloned human 5-HT1A, 5-HT1D alpha, 5-HT1D bet
a and opossum kidney (OK) 5-HT1B receptor sites. 5-HT1 receptor-mediat
ed activity was studied by measuring the inhibition of forskolin-induc
ed cAMP formation in cell lines expressing these receptors (B-max (fmo
l/mg protein): human epitheloid carcinoma HeLa/5-HT1A : 1285, OK/5-HT1
B : 52, Chinese hamster ovary CHO-K1/5-HT1D alpha : 181 and CHO-K1/5-H
T1D beta : 685). GR 127,935 did not show S-HT1D beta receptor-mediated
agonist activity in permanently transfected CHO-K1 cells, whereas at
submicromolar and higher concentrations intrinsic agonist activity was
observed in HeLa/5-HT1A, OK/5-HT1B and CHO-K1/5-HT1D alpha cells. GR
127,935 showed potent (K-B value: 1.3 nM) and silent antagonism at CHO
-K1/5-HT1D beta receptor sites. The antagonist activity of 1 mu M of G
R 127,935 at CHO-K1/5-HT1D alpha and OK/5-HT1B receptor sites was only
partial and less pronounced. This contrasts with the silent antagonis
m of methiothepin at the 5-HT1D alpha (K-B value = 11.8 nM), 5-HT1D be
ta (K-B value = 6.9 nM) and 5-HT1B (K-B value = 49.3 nM) receptor subt
ypes. GR 127,935, when tested at 10 mu M, was found to be a weak and p
artial antagonist of HeLa/5-HT1A receptors. In conclusion, GR 127,935
is a potent and effective antagonist of cloned human 5-HT1D beta recep
tor sites in transfected CHO-K1 cells but is only able to partially an
tagonise CHO-K1/5-HT1D alpha, OK/5-HT1B and HeLa/5-HT1A receptor sites
at micromolar concentrations.